The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women

Phillip Patton, F. O. Calvo, V. Y. Fujimoto, E. R. Bergert, R. D. Kempers, R. J. Ryan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Fourteen healthy young women were studied through a control and a treatment menstrual cycle in two series of experiments. In the first series, they were given one of four doses of deglycosylated human chorionic gonadotropin (hCG) as a 24-hour infusion during the mid-luteal phase of the cycle. In these studies, there were no significant alterations of the length of the luteal phase of the treatment cycle, and there was no decrease in serum progesterone (P) during the infusion. In fact, serum P increased during the infusion. In the second series of studies, five subjects were given a 48-hour infusion of normal saline during the control cycle, and a 48-hour infusion of deglycosylated α-intact β-hCG during the treatment cycle, both being administered during the mid-luteal phase. Treatment did not alter luteal phase duration and, again, increased serum P. It is concluded that deglycosylated preparations of hCG are not clinically useful as luteinizing hormone antagonists, probably because of residual agonist activity.

Original languageEnglish (US)
Pages (from-to)620-625
Number of pages6
JournalFertility and Sterility
Volume49
Issue number4
StatePublished - 1988
Externally publishedYes

Fingerprint

Luteal Phase
Corpus Luteum
Serum
Hormone Antagonists
Therapeutics
Menstrual Cycle
Luteinizing Hormone
Progesterone
deglycosylated HCG

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Patton, P., Calvo, F. O., Fujimoto, V. Y., Bergert, E. R., Kempers, R. D., & Ryan, R. J. (1988). The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women. Fertility and Sterility, 49(4), 620-625.

The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women. / Patton, Phillip; Calvo, F. O.; Fujimoto, V. Y.; Bergert, E. R.; Kempers, R. D.; Ryan, R. J.

In: Fertility and Sterility, Vol. 49, No. 4, 1988, p. 620-625.

Research output: Contribution to journalArticle

Patton, P, Calvo, FO, Fujimoto, VY, Bergert, ER, Kempers, RD & Ryan, RJ 1988, 'The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women', Fertility and Sterility, vol. 49, no. 4, pp. 620-625.
Patton, Phillip ; Calvo, F. O. ; Fujimoto, V. Y. ; Bergert, E. R. ; Kempers, R. D. ; Ryan, R. J. / The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women. In: Fertility and Sterility. 1988 ; Vol. 49, No. 4. pp. 620-625.
@article{9aba5700dced4840a98186027e9af416,
title = "The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women",
abstract = "Fourteen healthy young women were studied through a control and a treatment menstrual cycle in two series of experiments. In the first series, they were given one of four doses of deglycosylated human chorionic gonadotropin (hCG) as a 24-hour infusion during the mid-luteal phase of the cycle. In these studies, there were no significant alterations of the length of the luteal phase of the treatment cycle, and there was no decrease in serum progesterone (P) during the infusion. In fact, serum P increased during the infusion. In the second series of studies, five subjects were given a 48-hour infusion of normal saline during the control cycle, and a 48-hour infusion of deglycosylated α-intact β-hCG during the treatment cycle, both being administered during the mid-luteal phase. Treatment did not alter luteal phase duration and, again, increased serum P. It is concluded that deglycosylated preparations of hCG are not clinically useful as luteinizing hormone antagonists, probably because of residual agonist activity.",
author = "Phillip Patton and Calvo, {F. O.} and Fujimoto, {V. Y.} and Bergert, {E. R.} and Kempers, {R. D.} and Ryan, {R. J.}",
year = "1988",
language = "English (US)",
volume = "49",
pages = "620--625",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women

AU - Patton, Phillip

AU - Calvo, F. O.

AU - Fujimoto, V. Y.

AU - Bergert, E. R.

AU - Kempers, R. D.

AU - Ryan, R. J.

PY - 1988

Y1 - 1988

N2 - Fourteen healthy young women were studied through a control and a treatment menstrual cycle in two series of experiments. In the first series, they were given one of four doses of deglycosylated human chorionic gonadotropin (hCG) as a 24-hour infusion during the mid-luteal phase of the cycle. In these studies, there were no significant alterations of the length of the luteal phase of the treatment cycle, and there was no decrease in serum progesterone (P) during the infusion. In fact, serum P increased during the infusion. In the second series of studies, five subjects were given a 48-hour infusion of normal saline during the control cycle, and a 48-hour infusion of deglycosylated α-intact β-hCG during the treatment cycle, both being administered during the mid-luteal phase. Treatment did not alter luteal phase duration and, again, increased serum P. It is concluded that deglycosylated preparations of hCG are not clinically useful as luteinizing hormone antagonists, probably because of residual agonist activity.

AB - Fourteen healthy young women were studied through a control and a treatment menstrual cycle in two series of experiments. In the first series, they were given one of four doses of deglycosylated human chorionic gonadotropin (hCG) as a 24-hour infusion during the mid-luteal phase of the cycle. In these studies, there were no significant alterations of the length of the luteal phase of the treatment cycle, and there was no decrease in serum progesterone (P) during the infusion. In fact, serum P increased during the infusion. In the second series of studies, five subjects were given a 48-hour infusion of normal saline during the control cycle, and a 48-hour infusion of deglycosylated α-intact β-hCG during the treatment cycle, both being administered during the mid-luteal phase. Treatment did not alter luteal phase duration and, again, increased serum P. It is concluded that deglycosylated preparations of hCG are not clinically useful as luteinizing hormone antagonists, probably because of residual agonist activity.

UR - http://www.scopus.com/inward/record.url?scp=0023943458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023943458&partnerID=8YFLogxK

M3 - Article

C2 - 3350157

AN - SCOPUS:0023943458

VL - 49

SP - 620

EP - 625

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 4

ER -